Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Magnus

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Immunology|October 1, 1993
On the association between amyloid fibrils and glycosaminoglycans; possible interactive role of Ca2+ and amyloid P-componentT Stenstad, J H Magnus, K Syse, et al.
Scandinavian Journal of Immunology|July 1, 1991
Glycosaminoglycans in extracts of cardiac amyloid fibrils from familial amyloid cardiomyopathy of Danish origin related to variant transthyretin Met 111J H Magnus, T Stenstad, S O Kolset, et al.
Scandinavian Journal of Immunology|February 1, 1993
Purification of amyloid-associated heparan sulphate proteoglycans and galactosaminoglycan free chains from human tissuesT Stenstad, J H Magnus, G Husby, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 1, 1998
[Hormone replacement therapy among Norwegian women. Self-reported use and sales of estrogen preparations]A J Søgaard, V Fønnebø, J H Magnus, et al.
The Biochemical Journal|November 15, 1992
Isolation and partial characterization of heparan sulphate proteoglycans from human hepatic amyloidJ H Magnus, T Stenstad, G Husby, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 27, 2000
Walking after stroke: does it matter? Changes in bone mineral density within the first 12 months after stroke. A longitudinal studyL Jørgensen, B K Jacobsen, T Wilsgaard, et al.
Scandinavian Journal of Rheumatology|January 1, 1991
Identification of glycosaminoglycans in human renal and splenic secondary AA amyloid fibril preparationsT Stenstad, J H Magnus, S O Kolset, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 30, 1996
[Osteoporosis. Knowledge and attitudes of the Norwegian population]R M Joakimsen, A J Søgaard, A Tollan, et al.
Scandinavian Journal of Rheumatology|January 1, 1993
Facial palsy and partial accommodative insufficiency associated with sulphasalazine treatment in a patient with ankylosing spondylitisJ H Magnus, H H Elverland, E G Olsen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 6, 2010
Does using lower limit of normal values enhance the ability of a single bone mineral density measure to predict fractures?Q Wu, J H Magnus, J C Rice, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|October 1, 1993
On the association between amyloid fibrils and glycosaminoglycans; possible interactive role of Ca2+ and amyloid P-componentT Stenstad, J H Magnus, K Syse, et al.
Scandinavian Journal of Immunology|July 1, 1991
Glycosaminoglycans in extracts of cardiac amyloid fibrils from familial amyloid cardiomyopathy of Danish origin related to variant transthyretin Met 111J H Magnus, T Stenstad, S O Kolset, et al.
Scandinavian Journal of Immunology|February 1, 1993
Purification of amyloid-associated heparan sulphate proteoglycans and galactosaminoglycan free chains from human tissuesT Stenstad, J H Magnus, G Husby, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 1, 1998
[Hormone replacement therapy among Norwegian women. Self-reported use and sales of estrogen preparations]A J Søgaard, V Fønnebø, J H Magnus, et al.
The Biochemical Journal|November 15, 1992
Isolation and partial characterization of heparan sulphate proteoglycans from human hepatic amyloidJ H Magnus, T Stenstad, G Husby, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 27, 2000
Walking after stroke: does it matter? Changes in bone mineral density within the first 12 months after stroke. A longitudinal studyL Jørgensen, B K Jacobsen, T Wilsgaard, et al.
Scandinavian Journal of Rheumatology|January 1, 1991
Identification of glycosaminoglycans in human renal and splenic secondary AA amyloid fibril preparationsT Stenstad, J H Magnus, S O Kolset, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 30, 1996
[Osteoporosis. Knowledge and attitudes of the Norwegian population]R M Joakimsen, A J Søgaard, A Tollan, et al.
Scandinavian Journal of Rheumatology|January 1, 1993
Facial palsy and partial accommodative insufficiency associated with sulphasalazine treatment in a patient with ankylosing spondylitisJ H Magnus, H H Elverland, E G Olsen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 6, 2010
Does using lower limit of normal values enhance the ability of a single bone mineral density measure to predict fractures?Q Wu, J H Magnus, J C Rice, et al.
Pageof 5